Literature DB >> 3010455

Regulation of class III major histocompatibility complex gene products by interleukin-1.

D H Perlmutter, G Goldberger, C A Dinarello, S B Mizel, H R Colten.   

Abstract

Interleukin-1 (IL-1) is a product of mononuclear phagocytes that mediates changes characteristic of the response to inflammation or tissue injury (the acute-phase response). One of two structurally and functionally homologous major histocompatibility complex (MHC) class III genes encodes a positive acute-phase protein, complement factor B. The closely linked complement C2 gene is not affected during the acute-phase response. Purified human IL-1, pH 7.0, and recombinant-generated murine IL-1, pH 5.0, increased the expression of factor B and other positive acute-phase proteins in human hepatoma cells but decreased the expression of albumin, a negative acute-phase reactant. Furthermore, in a murine fibroblast L-cell line transfected with cosmid DNA bearing the human C2 and factor B genes, IL-1 mediated a reversible dose- and time-dependent increase in factor B expression in the transfected cells. Expression of the C2 gene was not affected by IL-1. The effect of IL-1 on factor B expression involves a mechanism acting at a pre-translational level as demonstrated by an increase in specific messenger RNA content and a corresponding increase in biosynthesis and secretion of factor B. The structural basis and mechanism for selective and independent regulation of these genes provides insight into the molecular control of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010455     DOI: 10.1126/science.3010455

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  36 in total

1.  Two high-affinity interleukin 1 receptors represent separate gene products.

Authors:  R Chizzonite; T Truitt; P L Kilian; A S Stern; P Nunes; K P Parker; K L Kaffka; A O Chua; D K Lugg; U Gubler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.

Authors:  D H Perlmutter; C A Dinarello; P I Punsal; H R Colten
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 3.  Hepatic acute phase reaction in vivo and in vitro.

Authors:  H Baumann
Journal:  In Vitro Cell Dev Biol       Date:  1989-02

4.  Identification of the promoter sequences involved in the interleukin-6 dependent expression of the rat alpha 2-macroglobulin gene.

Authors:  D Kunz; R Zimmermann; M Heisig; P C Heinrich
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

5.  Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors.

Authors:  M Trauner; M Arrese; H Lee; J L Boyer; S J Karpen
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Regulation of rabbit acute phase protein biosynthesis by monokines.

Authors:  A Mackiewicz; M K Ganapathi; D Schultz; D Samols; J Reese; I Kushner
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

7.  Stimulation of complement component C3 synthesis in macrophagelike cell lines by group B streptococci.

Authors:  K J Goodrum
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

8.  Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency.

Authors:  D H Perlmutter; J Travis; P I Punsal
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

9.  Cellular specificity of murine renal C3 expression in two models of inflammation.

Authors:  B H Ault; H R Colten
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

10.  Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis.

Authors:  J Passwell; G F Schreiner; M Nonaka; H U Beuscher; H R Colten
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.